With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.20485-41-0,4-Methylthiazole-5-carboxylic acid,as a common compound, the synthetic route is as follows.
The title compound N-[5(S)-3-[4-(1-cyanocyclopropan-1-yl)phenyl]-2-oxooxazolidin-5-ylmethyl]-(4-methyl-1,3-thiazole)-5-carboxamide (215 mg) was prepared from 5(S)-aminomethyl-3-[4-(1-cyanocyclopropan-1-yl)phenyl]oxazolidin-2-one (150 mg) and 4-methyl-1,3-thiadiazole-5-carboxylic acid (100 mg) in the same manner as described for EXAMPLE 62. [0516] MS (EI+) m/z: 382 (M+). [0517] HRMS (EI+) for C19H18N4O3S (M+): calcd, 382.1100; found, 382.1121.
20485-41-0, As the paragraph descriping shows that 20485-41-0 is playing an increasingly important role.
Reference£º
Patent; Fukuda, Yasumichi; US2003/225107; (2003); A1;,
Thiazole | C3H3NS – PubChem
Thiazole | chemical compound | Britannica